Sorbact® is a registered trademark owned by ABIGO Medical ABlogo
Evidence

Proven to prevent and treat wound infection

Proven in more than 40 clinical studies and in publications including over 7,000 patients, Sorbact® has more than 30 years of successful use in clinical practice. Today Sorbact® is helping patients in over 65 countries around the world and we are continuing this important work by collecting clinical data.

This is a selection of scientific articles about Sorbact®.

Studies

  • Bateman S. 2015 Evidence is building to support using a DACC-coated antimicrobial wound contact layer with NPWT
    Wounds UK. 11(1):82-86
  • Boyar V. 2016 Efficacy of Dialkylcarbamoylchloride-Coated Dressing in Management of Colonized or Infected Neonatal and Pediatric Wounds
    J Wound Ostomy Continence Nurs. 43(4):547-550
  • Bua N, Smith GE, et al. 2017 Dialkylcarbamoyl Chloride Dressings in the Prevention of Surgical Site Infections after Nonimplant Vascular Surgery
    Ann Vasc Surg. 44:387-392
  • Bullough L, Little G, et al. 2012 The use of DACC-coated dressings for the treatment of infected, complex abdominal wounds
    Wounds UK. 8(4):102-109
  • Chadwick P and Ousey K. 2019 Bacterial-binding dressings in the management of wound healing and infection prevention: A narrative review
    J Wound Care. 28(6):370-382
  • Choi JS, Lee JH, et al. 2015 Hydrogel-impregnated dressings for graft fixation: A case series
    J Wound Care. 24(7):326-328
  • Ciliberti M, De Lara F, et al. 2016 The effect of a bacteria- and fungi-binding mesh dressing on the bacterial load of pressure ulcers treated with negative pressure wound therapy: A pilot study
    Wounds. 28(11):408-420
  • Cooper R and Jenkins L. 2016 Binding of two bacterial biofilms to dialkyl carbamoyl chloride (DACC)-coated dressings in vitro
    J Wound Care. 25(2):76, 78-82
  • Dwiyana RF, Gondokaryono SP, et al. 2019 Clinical efficacy of dialkylcarbamoylchloride-coated cotton acetate dressing versus combination of normal saline dressing and 2 % mupirocin ointment in infected wounds of epidermolysis bullosa
    Dermatologic therapy. 32(5):e13047
  • Gentili V, Gianesini S, et al. 2012 Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed Sorbact
    Eur J Clin Microbiol Infect Dis. 31(7):1523-1529
  • Geroult S, Phillips RO, et al. 2014 Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings
    J Wound Care. 23(8):417-418, 422-424
  • Hampton S. 2007 An evaluation of the efficacy of Cutimed Sorbact in different types of non-healing wounds
    Wounds UK. 3(4):113-119
  • Haycocks S and Chadwick P. 2011 Use of DACC-coated dressings in diabetic foot ulcers: A case series
    Diabet Foot J. 14(3):133-137 
  • Johansson A, Ljungh Å, et al. 2009 Open study on the topical treatment of interdigital fungal infections in diabetic patients
    J Wound Care. 18(11):470, 472-473
  • Kammerlander G, Locher E, et al. 2008 An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management
    Wounds UK. 4(2):10-18
  • Ljungh Å, Yanagisawa N, et al. 2006 Using the principle of hydrophobic interaction to bind and remove wound bacteria
    J Wound Care. 15(4):175-180
  • Malmsjö M, Ingemansson R, et al. 2012 Comparison of bacteria and fungus‐binding mesh, foam and gauze as fillers in negative pressure wound therapy – pressure transduction, wound edge contraction, microvascular blood flow and fluid retention
    Int Wound J. 10(5):597-605
  • Malmsjö M, Lindstedt S, et al. 2014 Use of bacteria- and fungus-binding mesh in negative pressure wound therapy provides significant granulation tissue without tissue ingrowth
    Eplasty. 14:e3
  • Mosti G, Magliaro A, et al. 2015 Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study
    J Wound Care. 24(3):121-122, 124-127
  • Mussi C and Salvioli G. 2004 Clinical evaluation of Sorbact in the treatment of infected pressure sores
    Acta Vulnologica. 2(1-2):9-11
  • Powell G. 2009 Evaluating Cutimed Sorbact: Using a Case Study Approach
    Br J Nurs. 18(15):30, 32-36
  • Romain B, Mielcarek M, et al. 2020 Dialkylcarbamoyl chloride-coated versus alginate dressings after pilonidal sinus excision: a randomized clinical trial (SORKYSA study)
    BJS Open. 4(2):225-231
  • Ronner AC, Curtin J, et al. 2014 Adhesion of meticillin-resistant Staphylococcus aureus to DACC-coated dressings
    J Wound Care. 23(10):484, 486-488
  • Skinner R, Hampton S. 2010 The diabetic foot: managing infection using Cutimed Sorbact dressings
    Br J Nurs. 19(11):30, 32-36
  • Stanirowski PJ, Bizoń M, et al. 2016 Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing cesarean section
    Surg Infect (Larchmt). 17(4):427-435
  • Stanirowski PJ, Davies H, et al. 2019 Cost-effectiveness of a bacterial-binding dressing to prevent surgical site infection following caesarean section
    J Wound Care. 28(4):222-228
  • Stanirowski PJ, Kociszewska A, et al. 2016 Dialkylcarbamoyl chloride-impregnated dressing for the prevention of surgical site infection in women undergoing cesarean section: a pilot study
    Arch Med Sci. 12(5):1036-1042
  • Stephen-Haynes J, Leak K, et al. 2010 Cutimed® Siltec foam and Cutimed® Sorbact® gel dressings: a clinical audit
    Wounds UK. 6(1):130-136
  • Totty JP, Bua N, et al. 2017 Dialkylcarbamoyl chloride (DACC)-coated dressings in the management and prevention of wound infection: A systematic review
    J Wound Care. 26(3):107-114
  • Totty JP, Hitchman LH, et al. 2019 A pilot feasibility randomised clinical trial comparing dialkylcarbamoylchloride-coated dressings versus standard care for the primary prevention of surgical site infection
    Int Wound J. 16(4):1-8

Posters

  • Budi Susilo Y and Husmark J. 2019 DACC coated wound dressing and endotoxin: Investigation on binding ability and effect on endotoxin release from gram-negative bacteria
    EWMA 2019. EP167
  • Budi Susilo Y, Mattsby-Baltzer I, et al. 2020 Significant and rapid reduction of free endotoxin concentration by dialkylcarbamoyl chloride (dacc)-coated wound dressing
    SAWC 2020. LR-077
  • Husmark J and Arvidsson A. 2019 Evaluation of moisture donating capacity of six different wound gels in vitro
    EWMA 2019. PP019  
  • Husmark J, Arvidsson A, et al. 2020 Antimicrobial effect of a DACC-coated bacteria-binding wound dressing against WHO pathogens
    EWMA 2020. EP006

Consensus and Guidelines

  • Apelqvist J, Willy C, et al. 2017 EWMA Document: Negative pressure wound therapy overview, challenges and perspectives
    J Wound Care. 26(3):1-113
  • Atkin L, Bućko Z, et al. 2019 Implementing Timers: the race against hard-to-heal wounds
    J Wound Care. 28(3):1-49
  • Childs C, Sandy-Hodgetts K, et al. 2020 Risk, prevention and management of complications after vaginal and caesarean section birth
    J Wound Care. 29(Sup11a)
  • NICE. 2019 Leukomed Sorbact for preventing surgical site infection
    NICE National Institute for Health and Care Excellence. 1-11
  • Ousey K, Chadwick P, et al. 2018. Identifying and treating foot ulcers in patients with diabetes: saving feet, legs and lives
    J Wound Care. 27(Sup5):1-52
  • Stryja J, Sandy-Hodgetts K, et al. 2020 Surgical site infection: preventing and managing surgical site infection across health care sectors
    J Wound Care. 29(Sup2b):1-72

Unsupported browser

This site probably won't work great in Internet Explorer. We generally only support the recent versions of major browsers like Chrome, Firefox, Safari and Edge.